.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Argus Health
Johnson and Johnson
Queensland Health
Healthtrust
Federal Trade Commission
Harvard Business School
Cerilliant
Express Scripts
US Department of Justice

Generated: June 28, 2017

DrugPatentWatch Database Preview

Mafenide acetate - Generic Drug Details

« Back to Dashboard

What are the generic sources for mafenide acetate and what is the scope of mafenide acetate patent protection?

Mafenide acetate
is the generic ingredient in two branded drugs marketed by Par Form and Mylan Institutional, and is included in three NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for mafenide acetate. Two suppliers are listed for this compound.

Summary for Generic Name: mafenide acetate

Tradenames:2
Patents:1
Applicants:2
NDAs:3
Drug Master File Entries: see list3
Suppliers / Packagers: see list2
Bulk Api Vendors: see list53
Clinical Trials: see list902
Patent Applications: see list677
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:mafenide acetate at DailyMed

Pharmacology for Ingredient: mafenide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe
Mylan Institutional
SULFAMYLON
mafenide acetate
FOR SOLUTION;TOPICAL019832-003Jun 5, 1998ATRXYesYes► Subscribe► Subscribe
Par Form
MAFENIDE ACETATE
mafenide acetate
FOR SOLUTION;TOPICAL201511-001Feb 12, 2013ATRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: mafenide acetate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 19823,497,599► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Farmers Insurance
Federal Trade Commission
Novartis
Julphar
Argus Health
Colorcon
Johnson and Johnson
Cantor Fitzgerald
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot